Delaware Clinical and Translational Research ACCEL Program

特拉华州临床和转化研究 ACCEL 计划

• 批准号: 10437677
• 负责人: Gregory E Hicks
• 金额: $ 400万
• 依托单位: UNIVERSITY OF DELAWARE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-25 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10437677
• 关键词: Address; Adult; African American; American; Area; Asian; Award; Biometry; Budgets; Caring; Caucasians; Child Health; Childhood; Clinical Research; Columbidae; Community Outreach; Delaware; Development; Engineering; Evaluation; Foundations; Funding; Goals; Grant; Growth; Guidelines; Health; Health Promotion; Health system; Healthcare; Healthcare Systems; Hispanic; Hospitals; Infrastructure; Institution; Intention; Lead; Leadership; Letters; Medical; Modeling; Modification; Native Americans; Outreach Research; Pediatric Hospitals; Pilot Projects; Population; Population Heterogeneity; Research; Research Design; Research Personnel; Rural; Scientist; South Carolina; Structure; System; Time; Training; Translational Research; United States National Institutes of Health; Universities; Work; Writing; base; clinical infrastructure; community engagement; epidemiology study; improved; innovation; population health; programs; racial and ethnic; racial diversity; recruit; success; translational research program

Abstract—Overall This proposal is a competitive renewal of the IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54) grant originally awarded in September 2013. The program, titled the Delaware CTR ACCEL Program, has thus currently completed four years of funding at the time of this application. The overall goal of the ACCEL Program remains to provide the key components to allow growth in strategic areas to improve the health of the citizens of Delaware and the nation. Our consortium currently consists of four partners: University of Delaware (UD)—the lead institution; A.I. DuPont Hospital for Children, a part of the Nemours Children’s Health System (Ne- mours); Christiana Care Hospital System (CCHS), the largest health care sys-tem in the state of Delaware; and the Medical University of South Carolina (MUSC), our out-of-state IDeA partner. In this competitive renewal, we will expand our consortium to include Delaware State University (DSU), an American historically black, public univer- sity located in Dover, Delaware. Delaware is an ideal state for a CTR grant as it represents the whole of the USA in a compact form. The population of Delaware (~950,000) mirrors the US population in urban-to-rural citizen ratio and ethnic/racial diversity, with 22% African American, 69% Caucasian, 8% Hispanic, 3% Asian and 1% Native American. The dominance of adult (CCHS) and pediatric (Nemours) hospital systems, which serve at least 85% of the residents of the state, provides a unique opportunity to treat the state of Delaware as a model for examining how healthcare changes can impact population health. Similar to the strong support the ACCEL Program currently enjoys, the part- nering institutions and the State have again agreed to provide over $8.3 M in funds to support ACCEL related activi- ties. The structure and activities of the ACCEL Program have been modified in this competitive renewal. The ACCEL Program now only includes the Administrative Core and the five required key component activities. In addition, based on lessons learned, opportunities discovered, and success achieved, we have made substantive exciting changes to every component of the ACCEL Program. The Overall Specific Aims for the ACCEL Program are to: 1) Provide op- portunities and infrastructure that enhance the ability of outstanding investigators to conduct exciting and impactful clinical and translational research programs in areas of need and opportunity. 2) Recruit, train, and develop clini- cians, scientists, and engineers who will develop innovative, competitive, interdisciplinary, and interinstitutional clin- ical and translational research teams, and 3) Expand and enhance model community engagement outreach research programs that work with the State and other stakeholders to promote health and wellness to a diverse population of Delawareans. The leadership of the ACCEL program is proud of the strong foundation we have created over the past four years and looks forward to continuing to grow clinical and translational research programs that address some of the most important health care needs of Delawareans and all Americans.

摘要 - 全部 该提案是对临床和转化研究的Ideas计划基础设施的竞争续约 （IDEA-CTR）（U54）最初于2013年9月授予的赠款。该计划的标题为特拉华州CTR ACCEL 因此，在此申请时，计划目前已经完成了四年的资金。总体目标 加速计划仍然提供关键组成部分，以允许战略领域的增长以改善 特拉华州和国家的公民。我们的财团目前由四个合作伙伴组成：特拉华大学 （UD） - 主要机构；人工智能。杜邦儿童医院，Nemours儿童卫生系统的一部分（NE- 哀悼）；克里斯蒂安娜（Christiana）护理医院系统（CCHS），是特拉华州最大的医疗保健系统；和 南卡罗来纳州医科大学（MUSC），我们的州外构想合作伙伴。在这种竞争性续约中，我们将 将我们的财团扩展到包括特拉华州立大学（DSU），这是美国历史上的黑人公共宇宙 - 位于特拉华州多佛的智慧。特拉华州是CTR赠款的理想状态，因为它代表了整个美国 紧凑的形式。特拉华州的人口（〜950,000）反映了美国城市公民比例的美国人口 种族/种族多样性，有22％的非裔美国人，69％的白种人，8％的西班牙裔，3％的亚洲人和1％的美国原住民。 成人（CCHS）和小儿（Nemours）医院系统的优势，至少为85％的居民服务 该州提供了一个独特的机会，可以将特拉华州作为研究医疗保健的模型 变化会影响人口健康。与当前加速计划的强大支持类似，部分 Neuring机构和国家再次同意提供超过$ 8.3 m的资金，以支持与加速相关的活动 关系。加速计划的结构和活动已在此竞争更新中进行了修改。加速 现在，程序仅包括管理核心和所需的五个关键组件活动。此外， 根据所学到的经验教训，发现的机会以及取得的成功，我们做出了令人兴奋的更改 到加速程序的每个组件。加速计划的总体具体目标是：1）提供操作 港口和基础设施增强了杰出调查员进行令人兴奋和影响力的能力 在需要和机会领域的临床和翻译研究计划。 2）招募，培训和发展诊所 - CIAN，科学家和工程师将开发创新，竞争，跨学科和跨机构的临床 ICAL和翻译研究团队，以及3）扩展和增强模型社区参与外展研究 与州和其他利益相关者合作的计划，以促进健康和健康为多样性人群 德拉瓦人。 加速计划的领导以我们在过去四年中创造的强大基础感到自豪 并期待继续发展临床和翻译研究计划，以解决一些 特拉华州和所有美国人的最重要的医疗保健需求。